Physician-dentist dual referral model concept for coordinated bone anabolic therapy.
| Autor: | Latimer JM, Travan S, Berkey FD, Sugai JV, Giannobile WV |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of the American Dental Association (1939) [J Am Dent Assoc] 2024 Nov; Vol. 155 (11), pp. 954-962.e1. Date of Electronic Publication: 2024 Oct 05. |
| DOI: | 10.1016/j.adaj.2024.08.009 |
| Abstrakt: | Background: Bone anabolic drugs used for the pharmacologic treatment of osteoporosis have the potential to enhance alveolar bone regeneration to improve implant success. There are no US Food and Drug Administration-approved drugs indicated to improve oral bone density around teeth or implants. Methods: The authors summarized expert opinions on a novel coordinated treatment approach leveraging the effects of systemic bone anabolic drugs to enhance dental implant therapy in patients with osteoporosis and a dual referral model for physicians and dentists to address the clinical needs of patients with osteoporosis from a comprehensive perspective of oral-systemic health. Interviews of key opinion leaders were conducted with a bone health specialist group consisting of specialists in orthopedic surgery, internal medicine, geriatrics, endocrinology, and clinical densitometry and a surgical dental specialist group consisting of periodontists and oral surgeons. Results: Overall, both groups shared positive feedback on the idea of strategically timing administration of anabolic osteoporosis drugs with dental treatment. Both groups expressed interest in the dual referral model. Conclusions: The feedback of key opinion leaders supported the coordinated bone anabolic therapy concept and identified a need for improved interdisciplinary collaboration, education, and communication to realize the synergies of physician-dentist clinical cooperation. Practical Implications: Strategic timing of osteoporosis therapy could improve skeletal bone health and reduce fracture risk while offering adjunctive dental benefits. Competing Interests: Disclosure Dr. Berkey is the president of The Avenues Company. None of the other authors reported any disclosures. (Copyright © 2024 American Dental Association. Published by Elsevier Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|